Features
In This Issue: We dive into sustainable practices in the pharma industry and effective ways to safely implement them.
Sustainability principles can be effectively integrated into commissioning and qualification (C&Q) projects to support environmental goals without compromising compliance, quality, or patient safety. By positioning C&Q as both a verification tool and an enabler of sustainable intent, this article outlines a practical path for the pharmaceutical sector to enhance operational efficiency,...
The pharmaceutical industry’s embrace of digital technologies and sustainability is no longer a competitive advantage, but an operational necessity. As Pharma 4.0™ matures, its integration will be vital for achieving net-zero objectives and achieving pharmaceutical excellence.
Crafting a sustainable packaging strategy for the pharmaceutical industry is complex and requires balancing environmental responsibility with regulatory compliance and operational costs. In this article, we explore the key drivers, challenges, and best practices for developing such a strategy.
The development of platform drug delivery devices for combination products offers a transformative approach to drug delivery by enabling the reuse of device data across multiple drug and device combinations.
Oligonucleotide therapies hold great promise for treating a wide range of diseases, including the undruggable, but their journey from lab to patient hinges on fundamental manufacturing challenges that the industry is racing to solve.
Michelle Vuolo is currently Head of Quality at Tulip Interfaces, Inc., a platform developer that enables manufacturers of many industries to build digital content to manage their operations. Before joining Tulip, Michelle spent more than 24 years in the biopharmaceutical and medical devices industries in quality control (QC) laboratories, engineering technical support, quality assurance...
Stephanie Stärkle is a project engineer at VTU Engineering in Switzerland, where she leads engineering projects from concept to execution in GMP-regulated environments including cost estimation, equipment design and specification, deadline management, and coordination with cross-functional stakeholders such as vendors, quality assurance, operations, and qualification. She holds a bachelor’s...
Water and steam are essential in the pharmaceutical industry. Both are used for multiple purposes, including cleaning and sterilizing equipment, laboratory activities, and as an ingredient.
When I began my career as an engineer in a major pharmaceutical company, I worked in an engineering department filled with highly experienced senior engineers. I admired their depth of knowledge and the way they had accumulated a wealth of practical information over decades. Their grasp of systems, processes, and equipment was impressive and humbling. I found myself anxious to build that same...
Advancements in technology—such as process intensification, continuous manufacturing, and 3D printing—are enabling transportable and point-of-care (PoC) medicines manufacturing, especially with the rise of personalized medicine. Modular, small-scale production systems are particularly well-suited for cell and gene therapies and other advanced therapy medicinal products (ATMPs) designed for...
Simplified approaches that enable changes to analytical procedures over their lifecycle are needed to allow continual improvements and adaptations due to technological obsolescence and other challenges. This article reflects on the positive impact that the recent ICH Q14 guidance can have on facilitating these changes. Five examples are provided that are based on scenarios in which analytical...
The International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines, finalized in late 2023, outline strategies for analytical procedure development, validation, and lifecycle management. As global implementation progresses, ISPE’s PQLI® Analytical Method Strategy Team surveyed industry stakeholders in mid-2024 to assess readiness, identify opportunities, and highlight areas...
In April 2023, ISPE launched a survey to understand the sources of barriers to technological innovation within the pharmaceutical industry. This survey is part of an expansive and significant initiative by ISPE, Enabling Global Pharma Innovation: Delivering for Patients, which aims to promote consistent and harmonized interpretation and implementation of guidelines issued by the International...
Defining requirements for calibration and routine testing of weighing equipment in the laboratory and production remains a complex endeavor for pharmaceutical companies. Applying sound, risk-based metrological strategies across the entire pharmaceutical value chain will help manufacturers ensure compliance, consumer safety, and commercial success.
The United States Pharmacopeia (USP) Packaging and Distribution Expert Committee approved chapters 665 and 1665 in 2024. These chapters establish clear and general guidelines for the use of plastic materials in process equipment used within the pharmaceutical and biotechnology industries. Their publication has raised new questions regarding the role of polymeric materials in manufacturing...
The increasing digitalization of the pharmaceutical and medical device industry has created novel cybersecurity challenges, particularly with the rapid advancement of artificial intelligence (AI) technologies. This article examines the dual nature of AI as both a potential threat vector and a powerful defensive tool.
The move to digital transformation represents a true paradigm shift in manufacturing, enabling organizations to leverage advanced technologies such as the Industrial Internet of Things (IIoT), cloud computing, and artificial intelligence (AI) to ensure compliance and secure a competitive advantage. This article presents a working definition of digital transformation, the components involved in...
Pharmaceutical companies can use digital maturity assessments to address the challenges of upgrading brownfield facilities and implementing digital transformation improvements. Enabled by stakeholder workshops, these assessments can rapidly produce concrete plans and priorities to guide a facility’s development over the next three to five years—delivering business value and laying the...
Pharma 4.0™ is a reference framework tailored to the pharmaceutical industry, guiding its digital transformation. Although many of today’s processes generate sufficient data to enable advanced use cases, structured guidance for transformation is often lacking. To address this, the ISPE Pharma 4.0™ Subcommittee on Process Data Maps and Critical Thinking has introduced an approach to help...
The often-overlooked function of chemistry, manufacturing, and controls (CMC) holds tremendous potential to reshape the landscape of drug development. By embracing innovation and rethinking traditional approaches, CMC has the rare opportunity to drive transformative changes that could significantly accelerate the journey from initial concept to a fully realized therapy. This offers the...
Currently, there is no single guidance document providing a comprehensive roadmap for executing digital validation. While elements from ISPE GAMP® Guides Series and the ISPE Baseline® Guide: Volume 8 – Pharma 4.0™, apply to digital validation, there is no consolidated resource addressing common questions. The authors of this Concept Paper therefore advocate for the development of a Good...
A set of principles to be considered in the journey to adopting and deploying an architecture capable of supporting Pharma 4.0 Plug & Produce capability.
For the first time in ISPE Pharma 4.0™ Conference history, ISPE will dedicate an entire track for the 2025 ISPE Pharma 4.0™ Conference to Process Analytical Technology (PAT)—in recognition of how central it has...
As industries across the globe navigate increasing complexity, consumer expectations, and regulatory pressures, the traditional boundaries of quality management are being pushed. Quality is no longer just a post-production checkpoint—it has become a strategic pillar that spans the entire product lifecycle. In this transformative landscape, artificial intelligence (AI) is emerging as a powerful...
In Pharma 4.0™, quality should no longer be reactive—it’s predictive, connected, and embedded in daily operations. The 2025 ISPE Pharma 4.0™ Conference, taking place 9–10 December in Barcelona, Spain, and...
C&Q forms a critical connection between the construction phase and operational readiness of pharmaceutical manufacturing facilities. Despite C&Q’s important role in regulatory compliance, many project leaders are not prioritizing this phase, treating it as optional, low value added, or merely a paperwork exercise. This situation can exist in engineering, procurements, and construction...
In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Eric Brown, Digital Developer in the Professional Development Department.
With nearly 2,000 drugs currently in shortage across the UK—a staggering increase from 1,608 just one year prior—the pharmaceutical industry faces an unprecedented crisis that demands immediate attention.
The rapid pace of digital innovation, offers plenty of unprecedented opportunities as well as a few unforeseen challenges. The ISPE Pharma 4.0™ Conference has been helping life science industry professionals embrace opportunities and overcome challenges since 2017. This year’s conference is no exception. We’ll examine EU GMP Chapter 4 Annex 11 and Annex 22’s new focus on emerging technologies...
In the heart of traditional Chinese kitchens lies a profound respect for resources: nothing is wasted, and simple ingredients and different flavors are combined to achieve a well-balanced meal through a defined process with suitable tools. What does ancient cuisine and modern pharmaceutical production have in common? And what could we learn in terms of sustainability?
As I conclude my tenure as Chair of the Women in Pharma® International Steering Committee, I reflect on a journey that has been professionally enriching and personally transformative.
ISPE reached new heights in its 45th year with the launch of the ISPE Academy, a new podcast, and the 20th anniversary of the Facility of the Year Awards (FOYA). As 2025 comes to a close, Pharmaceutical Engineering®...
Continuous manufacturing (CM) of oral solid dosage forms has become a well-established approach that offers multiple benefits in the production of pharmaceutical oral solid dosage forms as compared to traditional batch manufacturing. CM continues to offer opportunities for faster development and time to market, enhanced process robustness, improved quality assurance, and greater operational...
The pharmaceutical industry is under constant pressure to expand capacity, accelerate time-to-market, and ensure reliable access to critical medicines. As more therapies gain regulatory approval and blockbuster drugs scale rapidly, the need for smarter, more resilient facilities has never been greater. That is why ISPE is particularly excited about the Innovative Facility Design track at the...
The 2025 ISPE Annual Meeting & Expo is set for 26–29 October in Charlotte, North Carolina, USA and virtually. ISPE invited conference committee members, Peter Millili, Senior Director, Manufacturing...
The pace of innovation—digital joined with operational excellence—in the life sciences industry shows signs of improvement. Artificial intelligence, robotics, advanced analytics, smart facilities design and innovation culture are no longer “future concepts”—they are deeply transforming pharmaceutical development, manufacturing and the whole supply chain. Alongside many exciting opportunities...
Advanced therapy medicinal products (ATMPs) represent a revolutionary frontier in medicine, offering life-changing treatments for conditions previously deemed incurable. However, the intricate nature of these therapies, from their unique raw materials to complex manufacturing and logistics, presents significant challenges and inherent risks including how to best develop validation methods and...
This year’s ISPE Germany/Austria/Switzerland (D/A/CH) Affiliate workshop, “Pharma’s Journey to Digital Manufacturing and Supply,” united pharma leaders, technology experts and regulatory agencies for three days of intense exchanges on the digital transformation of our industry. Its innovative, highly interactive format enabled all 130 participants to engage, contribute, and learn from each...
A Message from the President and CEO, ISPE, on the 2025 ISPE Boston Product Show
Engineers know that data is only as valuable as the decisions it drives. The Data-Driven Manufacturing Excellence Solutions track at the 2025 ISPE Pharma 4.0™ Conference will showcase how pharma organizations...
The 2025 ISPE Annual Meeting & Expo, ISPE’s largest event of the year, is quickly approaching, taking place 26–29 October in Charlotte, North Carolina, USA and virtually. In the videos and transcripts...
Bayer, a global leader in the pharmaceutical industry, is committed to advancing healthcare through innovative solutions. With their new Cell Therapy Launch and Manufacturing Facility, Bayer aims to provide hope to patients with unmet medical needs by finding a cure and making life-changing therapies more accessible to all. The facility signifies a major advancement in the production and...
Artificial Intelligence isn’t just theory anymore—it’s revolutionizing pharmaceutical operations today. At this year’s 2025 ISPE Pharma 4.0™ Conference, the AI Case Studies: Benefits and Challenges track...
Sponsored content is the sole responsibility of the authors and is not endorsed, reviewed, nor a published article of Pharmaceutical Engineering® magazine or ISPE.
Across the country, data centers are being constructed at incredible speed. Pharmaceutical manufacturers should take notice. Despite complex MEP systems, on-site power generation and large site footprints, data centers are being designed and delivered in less than two...
This whitepaper explores the principles behind USP <1221>, how it aligns with related global regulatory efforts like USP <1220>, USP <1225>, and ICH Q14, and the role of modern informatics in supporting laboratories as they adapt to these new expectations. In particular, the whitepaper will examine how Waters™ integrated software solutions provide the digital infrastructure...
Whether networking at events or collaborating through our Communities of Practice, the value of an ISPE membership is in the connections made between pharmaceutical industry professionals and Regulators to collaborate on solutions to common goals and challenges.
Are you a subject-matter expert in the global pharmaceutical industry? Are you brimming with knowledge about the latest technical developments or regulatory initiatives? Have you found an innovative solution to a real-world challenge?
Contribute your knowledge and experience to the always-evolving pharmaceutical industry!
Do you know someone whose profile or work should be featured in Pharmaceutical Engineering? Contact ISPE Publications Department.